From grade-school “remedial” teaching to the Nobel stage, molecular biologist Carol W. Greider turned obstacles into fuel for ...
EMA committee recommends approval of Insmed’s Brinsupri to treat non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Monday, October 20, 2025, 15:00 Hrs [IST] Insmed Inc ...
Before cells can divide, they first need to replicate all of their chromosomes, so that each of the daughter cells can ...
If Approved, BRINSUPRI Would Be the First and Only Treatment in the European Union for Non-Cystic Fibrosis Bronchiectasis ...
News Medical on MSN
Pin1 inhibitors could reduce or stop outbreaks of herpes simplex virus 1
A class of antivirals called Pin1 inhibitors could reduce or stop outbreaks of herpes simplex virus 1 (HSV-1), the common infection behind oral herpes, according to new research published in Antiviral ...
A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated ...
Mission Therapeutics raises $13.3M to advance its USP30 inhibitor MTX325 into Phase I trials for Parkinson’s, targeting ...
An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, ...
5don MSNOpinion
The only thing standing between humanity and the end of HIV
A new drug called lenacapavir might entirely change the game, though.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback